Skip to main content
Top

17-05-2025 | Rheumatoid Arthritis | Review Article

Review of pulmonary manifestations of rheumatoid arthritis

Authors: Stella Chen, Susannah Kay

Published in: Skeletal Radiology

Login to get access

Abstract

Rheumatoid arthritis (RA) is a systemic autoinflammatory disorder that primarily affects joints. However, RA can involve extra-articular structures as well, including the lungs, affecting significant morbidity and mortality, though the precise mechanisms of extra-articular RA are still under investigation. Accurate diagnosis of these conditions can be challenging and requires a multidisciplinary approach. This review aims to describe proposed mechanisms of pulmonary RA and characterize common, clinically relevant pulmonary manifestations of RA, including parenchymal disease (interstitial lung disease and multiple pulmonary nodules), small and large airway involvement, and pleural effusions. In particular, CT imaging may reveal developing pulmonary disease before clinical symptoms present, revealing the importance of maintaining a high degree of suspicion for RA-related pulmonary disease.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Review of pulmonary manifestations of rheumatoid arthritis
Authors
Stella Chen
Susannah Kay
Publication date
17-05-2025
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-025-04930-5

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest